January 25, 2018 01:54 PM EST
China

Fast-grow­ing Shang­hai Phar­ma to plant foot in San Diego, hunt­ing deals in US and Eu­rope

Amber Tong

A mul­ti-bil­lion dol­lar Chi­nese phar­ma con­glom­er­ate, blessed with mu­nic­i­pal gov­ern­ment back­ing, is spread­ing its wings to the US and Eu­rope with eyes on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

A service from the Financial Times